Consultation on 1,3-bis(hydroxymethyl)-5,5-dimethylhydantoin and hydroxymethyl-5,5-dimethylhydantoin and Associated End-use Products, Proposed Re-evaluation Decision PRVD2022-10

Health Canada is consulting Canadians on the proposal to continue registration of products containing 1,3-bis(hydroxymethyl)-5,5-dimethylhydantoin (DMY) and hydroxymethyl-5,5-dimethylhydantoin (MMY) registered for sale and use in Canada. As a result of the re-evaluation of DMY and MMY, Health Canada proposes further risk-reduction measures in addition to those already identified on product labels.

DMY and MMY are antimicrobial material preservatives used in a wide variety of products such as liquid detergents, soft soaps, room deodorizers and air fresheners, water-based surfactants, polymer emulsions, protective and decorative coatings, water-based gels for household and industrial products, textiles, water-based adhesives, latex for paper and coatings, and water-based inks. DMY and MMY are of value in aiding in the prevention and control of bacterial and fungal contamination of aqueous-based materials. Such contaminations can lead to product failures of function or discolorations/unpleasant odours that will make the product unusable.

For a full list of products containing DMY and MMY, please consult Appendix I in the Proposed Re-evaluation Decision or visit the Pesticide Label Search database.

For more information on the proposed decision open the “Proposed Re-evaluation Decision”.

How to get involved

This consultation is open for comment from 30 May 2022 to 28 August 2022 (90 calendar days).

To comment on PRVD2022-10:

• Step 1 Request the full consultation document to read the Science Evaluation that is the basis of this proposed regulatory decision.
• Step 2 Submit comments to the PMRA Publications Section.

All comments received will be considered. A final re-evaluation decision will consider additional scientific information provided during the public comment period.

Please refer to the document title (for example: PRVD2022-10, 1,3-bis(hydroxymethyl)-5,5-dimethylhydantoin and hydroxymethyl-5,5-dimethylhydantoin and Associated End-use Products) when providing comments.

Reporting to Canadians

Health Canada will make the results of this consultation available on this website. Once the decision is finalized, the PMRA will post a Re-evaluation Decision on the Pesticides and Pest Management Reports and Publications portion of Canada.ca.

If you have any questions, contact the Pest Management Information Service.

Interested in our other consultations? Sign up and stay informed about topics that matter to you.